JAMA Network Open

作者须对提交给期刊的所有内容的准确性负责，并须审查并确认由人工智能（AI）、大语言模型（LLM）、聊天机器人或类似技术生成的所有内容的准确性，且须对此类内容承担全部责任。 模型中文摘要

Authors are responsible for the accuracy of all content submitted to the journal. Authors must review and confirm the accuracy of all content generated by artificial intelligence (AI), large language models (LLMs), chatbots, or similar technologies and must be accountable and take full responsibility for all content.

所有作者均须填写作者身份表和出版协议。 模型中文摘要

All authors are required to complete an Authorship Form and Publishing Agreement. See Authorship Criteria and Contributions. Back to top

JAMA Network 各期刊针对作者的大部分编辑政策已汇总于这些投稿说明中，并提供了《AMA写作手册》及其他含有补充信息的出版物的引用和链接。 模型中文摘要

Most of the JAMA Network journals' editorial policies for authors are summarized in these instructions. Citations and links to the AMA Manual of Style: A Guide for Authors and Editors2 and other publications with additional information are also provided.

对于所有包含原始数据的报告（无论资金来源如何），须由至少1名具名作者（如主要研究者）且不超过2名作者声明其“可完全获取研究中的全部数据，并对数据的完整性和数据分析的准确性负责”，该确切声明应写入稿件末尾的致谢部分；修改后的表述或表示所有作者均可获取数据的笼统表述不被接受。 模型中文摘要

For all reports (regardless of funding source) containing original data, at least 1 named author (eg, the principal investigator), and no more than 2 authors, must indicate that she or he "had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis."7 This exact statement should be included in the Acknowledgment section …

对于所有报告人类参与者或动物研究数据的稿件，须经过适当的机构审查委员会或伦理委员会的正式审查与批准（或正式审查与豁免），并应在方法部分加以说明；没有正式伦理审查委员会的研究者应遵循《赫尔辛基宣言》的原则；涉及人类的研究还应在方法部分说明获得知情同意的方式（口头或书面）。 模型中文摘要

For all manuscripts reporting data from studies involving human participants or animals, formal review and approval, or formal review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section.2(p226) For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Hel…

期刊在支付文章处理费（APC）并向期刊授予出版许可后，于出版当天在期刊网站免费开放获取所有被接收发表的研究文章，并会在出版时将已发表的研究文章存入PubMed Central（PMC）。 模型中文摘要

The journal makes all research articles that are accepted for publication freely available open access on the journal website on the day of publication following payment of article processing charges (APC) (see below) and grant of a Publication License to the journal. The journal will deposit a copy of the published research article into PubMed Central (PMC) at the time of publication. A few weeks…

作者将通过电子邮件收到稿件收稿通知和编辑决定通知，审稿过程中可通过在线投稿与审稿系统查询稿件状态；未经编辑许可，作者不得向共同作者和贡献者以外的任何人透露稿件已投稿的事实。 模型中文摘要

Authors will be sent notifications of the receipt of manuscripts and editorial decisions by email. During the review process, authors can check the status of their submitted manuscript via the online manuscript submission and review system. Authors should not disclose the fact that their manuscript has been submitted to anyone, except coauthors and contributors, without permission of the editor. I…

稿件被考虑的前提是其未曾发表且未同时投给其他出版物；同一作者所有相关或相似的、已发表或已电子发布或正在他处考虑的稿件和报告，须在投稿时一并提供，且所有相关的已发表文章应作为参考文献引用并在所投稿件中加以说明。 模型中文摘要

Manuscripts are considered with the understanding that they have not been published previously and are not under consideration by another publication. Copies of all related or similar manuscripts and reports by the same authors (ie, those containing substantially similar content or using the same, similar, or a subset of data) that have been previously published or posted electronically or are und…

稿件被接收后，未经编辑许可，作者不得向共同作者和贡献者以外的任何人透露稿件已被接收，直至其发表，除非按照既往或计划会议报告、信息发布与禁运政策指南所述进行。 模型中文摘要

Authors should not disclose the fact that their manuscript has been accepted to anyone, except coauthors and contributors, until it is published without permission of the editor or as described in the guidance on Previous or Planned Meeting Presentaton or Release of Information and Embargo Policy. Back to top

与ICMJE一致，JAMA Network要求作为发表考虑的条件，所有试验须在ICMJE认可的公共试验注册机构注册（即该注册机构须由非营利实体拥有、可公开访问，并要求ICMJE规定的最低注册数据集），可接受的注册机构包括clinicaltrials.gov等以及WHO国际临床试验注册平台所列的其他一级注册机构。 模型中文摘要

In concert with the ICMJE, JAMA Network requires, as a condition of consideration for publication, registration of all trials in a public trials registry that is acceptable to the ICMJE (ie, the registry must be owned by a not-for-profit entity, be publicly accessible, and require the minimum registration data set as described by ICMJE).4,8,9 Acceptable trial registries include the following and o…